Skip to main content
. 2023 Jun 16;15(6):1749. doi: 10.3390/pharmaceutics15061749

Figure 7.

Figure 7

FTIR spectra of: (a) sulfanilamide, (b) p(NIPAM) hydrogel 2.5 mol%, and (c) p(NIPAM) hydrogel 2.5 mol% with incorporated sulfanilamide.